Introduction
Introduction ( 5 Questions)
A nurse is administering enoxaparin, a low-molecular-weight heparin, to a client who has undergone orthopedic surgery. The nurse should administer this medication by which route and at which site?
Choice A is wrong because intramuscular injection in the deltoid muscle is not the recommended route or site for enoxaparin. Intramuscular injection may cause bleeding, bruising, or hematoma formation.
Subcutaneous injection in the abdomen. This is because enoxaparin is a low-molecular-weight heparin that is administered subcutaneously, usually in the abdomen or outer thigh. The drug should be clear and colorless or pale yellow. The dosage for adults is typically 30mg every 12 hours for 7 to 10 days, or 40mg once a day for 3 weeks after hip replacement surgery. The needle should be inserted fully into the skin and the syringe plunger should be pressed down to inject the drug. Injection sites should be rotated and areas of active skin disease or injury should be avoided.
Choice C is wrong because intravenous infusion in a peripheral vein is not the recommended route for enoxaparin. Enoxaparin can be given intravenously only as a bolus injection for acute coronary syndrome, not as an infusion.
Choice D is wrong because intradermal injection in the forearm is not the recommended route or site for enoxaparin. Intradermal injection may cause skin irritation, infection, or necrosis.
Subcutaneous injection in the abdomen. This is because enoxaparin is a low-molecular-weight heparin that is administered subcutaneously, usually in the abdomen or outer thigh. The drug should be clear and colorless or pale yellow. The dosage for adults is typically 30mg every 12 hours for 7 to 10 days, or 40mg once a day for 3 weeks after hip replacement surgery. The needle should be inserted fully into the skin and the syringe plunger should be pressed down to inject the drug. Injection sites should be rotated and areas of active skin disease or injury should be avoided.
Choice A is wrong because intramuscular injection in the deltoid muscle is not the recommended route or site for enoxaparin. Intramuscular injection may cause bleeding, bruising, or hematoma formation.
Choice C is wrong because intravenous infusion in a peripheral vein is not the recommended route for enoxaparin. Enoxaparin can be given intravenously only as a bolus injection for acute coronary syndrome, not as an infusion.
Choice D is wrong because intradermal injection in the forearm is not the recommended route or site for enoxaparin. Intradermal injection may cause skin irritation, infection, or necrosis.